BioHarvest Sciences Named Honorable Mention in Wellness Category of Fast Company's 2023 World Changing Ideas Awards
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 3, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) is pleased to announce that VINIA®, the first product developed on its proprietary Bio-Plant CELLicitation platform, has been recognized as an Honorable mention in the Wellness category of Fast Company’s 2023 World Changing Ideas Awards. This annual Fast Company award celebrates “the sustainable designs, innovative products, bold social initiatives, and other creative...
2023-05-03 8:00 AM EDT
BioHarvest Sciences Contributing VINIA to NFL Training Camp Preparation
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "company") has announced that its VINIA partnership with House of Athlete trainer Yo Murphy has resulted in several of his high-profile players entering the NFL draft as members of "Team VINIA." The red grape-based supplement has also been selected by multiple
2023-04-27 8:00 AM EDT
BioHarvest Sciences to Host Virtual Shareholder Presentation May 4, 2pm ET
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 26, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB:CNVCF) ("BioHarvest" or the "Company") announces that it is hosting a Shareholder Presentation on Thursday May 4, 2023, at 11am PST | 2 pm EST. The interactive session will be hosted by CEO Ilan Sobel, who will be joined by Chief Medical Officer Dr. Brian Cornblatt. Ilan Sobel will provide updates on current BioHarvest marketing initiatives, and Dr. Brian Cornblatt will...
2023-04-26 8:00 AM EDT
BioHarvest Sciences Hires Dr. Ilana Belzer as Chief Operating Officer
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 19, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company") has hired, effective today, Dr. Ilana Belzer, Ph.D., as its Chief Operating Officer (COO), reporting to CEO Ilan Sobel, marking a significant milestone in the Company's commitment to driving continued growth and a relentless focus on achieving profitability in the near term. Dr. Belzer brings extensive leadership experience and technical...
2023-04-19 7:00 AM EDT
BioHarvest Sciences Announces Major Media Campaign to Focus on VINIA Real Stories
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 4, 2023) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) (the Company) is announcing that its first major 2023 product marketing campaign has launched, titled "Real Stories". This campaign focuses on actual VINIA® users and their experiences, and it will include aggressive digital and social media marketing to support television content, which includes advertising content on major television networks, including Fox News, Hulu and...
2023-04-04 7:09 AM EDT
BioHarvest Sciences Announces a Private Placement of up to CAD $8M of Convertible Notes to Grow Core Business
Rehovot, Israel--(Newsfile Corp. - February 21, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company") announced today a private placement of up to CAD $8 Million of two year convertible notes (the "Notes). The funds raised will predominantly support the Company's growth in its polyphenols/antioxidan
2023-02-21 3:06 PM EST
BioHarvest Sciences Collaborating with Yo Murphy and NFL Prospects to Build Awareness of Blood Flow Importance
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 16, 2023) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) is announcing that it has paired with former
2023-02-16 9:15 AM EST
BioHarvest Sciences Announces Clinical Study in Patients with Multiple Sclerosis-Related Optic Neuritis
Rehovot, Israel--(Newsfile Corp. - February 14, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company") has announced a collaboration with the International Neurorehabilitation Institute (INI) (https://inirehab.com/) in Lutherville, Maryland to perform a clinical trial to assess the capacity of its
2023-02-14 7:00 AM EST
BioHarvest Sciences Reports 2022 Sales Orders of USD 6.1M Representing 2.6X Increase over 2021
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 9, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company") today announces sales orders results for the year 2022 following a strong quarter for VINIA® in both the United States and Israel. The USD 6.1M(1) of sales orders in 2022
2023-02-09 1:00 PM EST
BioHarvest Sciences Inc. Appoints Dr. George Garibaldi to Its Scientific Board of Advisors
British Columbia and Rehovot, Israel--(Newsfile Corp. - January 17, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "company") announces that effective immediately, Dr. George Garibaldi will serve on its Scientific Board of Advisors. Complementing a top-tier group that includes a significant array of expertise, Dr. Garibaldi brings BioHarvest 40 years of experience in drug development a
2023-01-17 7:30 AM EST
BioHarvest Sciences Inc. Announces Live Quarterly Shareholder Update Event January 19, 2023, at 2:00 PM E.T.
Rehovot, Israel--(Newsfile Corp. - January 11, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB:CNVCF) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, January 19, 2023, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host this first shareholder event of 2023, and will present the Q4 2022 VINIA® sales results, provide an update on Cannabis...
2023-01-11 8:00 AM EST
Bioharvest Sciences Inc. 2022 CEO Letter to Shareholder Partners
British Columbia and Rehovot, Israel--(Newsfile Corp. - December 29, 2022) - BioHarvest Sciences Inc.("BioHarvest" or the "Company") (CSE: BHSC) (OTCQB: CNVCF) is pleased to provide the following year-end shareholder partner letter from CEO Ilan Sobel. Dear Shareholder Partner, What a year 2022 was for BioHarvest! We made big steps in our journey to build a multi-billion-dollar biotech company with a clear vision of bringing millions of consumers the next generation of science-based...
2022-12-29 8:30 AM EST
BioHarvest Sciences Inc. Projects 2023 Revenue to Grow 3.0X-3.5X to a Range of USD $17M-$20M
British Columbia and Rehovot, Israel--(Newsfile Corp. - December 15, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or "the Company") is estimating 2023 revenue to be between USD $17M-20M, representing a significant growth of at least 3X over 2022. Revenue for 2022 is now estimated to be USD $5.5M-$5.7M, meeting the guidance range provided by the company in Q1 of this year. The Company is also projecting to achieve cash flow break-even in Q4 2023. BioHarvest plans...
2022-12-15 7:00 AM EST
Royal Emerald Pharmaceuticals Partners with BioHarvest Sciences to Supply Disruptive Cannabis Solutions to Companies Conducting FDA-Approved Medical Research
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 16, 2022) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV), a leading biotech company focused on plant bio-cells growth for the nutraceutical and the medicinal cannabis markets, today announced the signing of a binding Letter of Intent (LOI) with Royal Emerald Pharmaceuticals (REP), one of only seven Drug Enforcement Administration (DEA) bulk manufacturing registration holders permitted to grow marijuana in the United...
2022-11-16 7:44 AM EST
BioHarvest Sciences Inc. Announces Closing of the Second Tranche of Private Placement of Convertible Notes and Expects the Offering to Be Oversubscribed and to Close an Additional Tranche of up to $3 Million by December 15, 2022
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 15, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its non-brokered private placement of convertible notes (the "Notes") previously announced on October 7, 2022. Due to the significant demand for this offering, the Company expects the offering to be oversubscribed and to close an...
2022-11-15 1:56 PM EST
BioHarvest Sciences CEO to Detail Multi-Pronged Cannabis Strategy in North America at Online Webinar, Nov 16 at 2pm ET
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 14, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that CEO Ilan Sobel will host an online investor presentation on Wednesday, November 16. Following the October 25th breakthrough achievement and other important recent developments at BHSC and in the Cannabis market, the Company invites all interested investors and media to register for this event, where Ilan...
2022-11-14 1:59 PM EST
BioHarvest Introduces its 1st Cannabis Breakthrough Composition with Major Medical and Commercial Implications
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 25, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") reveals today the detailed anal
2022-10-25 8:05 AM EDT
BioHarvest Sciences Inc. Announces Closing of the First Tranche of Private Placement of Convertible Notes
Rehovot, Israel--(Newsfile Corp. - October 13, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its non-brokered private placement of convertible notes (the "Notes") previously announced on April 7, 2022 and October 7, 2022. Under the First Tranche, the Company has issued Notes in the aggregate principal amount of $6,878,243.65 CAD. In connection with the...
2022-10-13 7:30 AM EDT
BioHarvest Sciences Inc. Announces the Oversubscription of Private Placement of Convertible Notes and Change in Note Terms.
Rehovot, Israel--(Newsfile Corp. - October 7, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that its non-brokered private placement of convertible notes (the "Notes") previously announced of up to $6,300,000 CAD has been oversubscribed and has now been increased to up to $10,000,000 CAD in order to further accelerate VINIA® sales growth and Cannabis commercialization activities in North America. The Company also...
2022-10-07 7:30 AM EDT
BioHarvest Sciences Inc. Reports Record Sales Results in Q3 2022 with Strong Momentum Building on All Fronts
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 3, 2022) - BioHarvest Sciences Inc. (CS
2022-10-03 7:30 AM EDT